Development of Monoclonal Antibody-mediated Interventions to Combat Malaria

NIH RePORTER · NIH · N43 · $300,000 · view on reporter.nih.gov ↗

Abstract

To support proof of concept studies for the development of a monoclonal antibody to combat malaria.

Key facts

NIH application ID: 10706432
Project number: 75N93022C00020-0-9999-1
Recipient: ANTAGEN PHARMACEUTICALS, INC.
Principal Investigator: WENDA GAO
Activity code: N43
Funding institute: NIH
Fiscal year: 2022
Award amount: $300,000
Award type: —
Project period: 2022-07-05 → —